Paper

0

Document

Submit new version

Download

Flag content

0

Patient-Reported Outcomes in Adults With Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia Treated With Ponatinib or Imatinib in Combination With Reduced-Intensity Chemotherapy: Results From the Phase III PhALLCON Study

Internal Medicine

Show More

Authors

Ajibade Ashaye,Ling Shi

Ibrahim Aldoss,Pau Montesinos,Pankit Vachhani,Vanderson Rocha,Cristina Papayannidis,Jessica Leonard,Maria Baer,Josep‐María Ribera,James McCloskey,Jianxiang Wang,Jie Jin,Sujun Gao,Deepali Rane,Shien Guo

+14 authors

,Josep‐Marǐa Ribera

Journal

Clinical Lymphoma Myeloma & Leukemia

Published

Sep 1, 2024

DOI

10.1016/s2152-2650(24)00432-4

Show more

Save

Tip

Document

Submit new version

Download

Flag content

0

Tip

Save

Document

Submit new version

Download

Flag content

Abstract

Paper PDF

This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.